Skip to main content

Table 4 Patient demographics and number of abdominal attacks in patients treated with 30 mg subcutaneous ecallantide 1

From: Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency

  Patients (N = 149)
Patient demographics  
Number of attacks 521
Age, mean (range) 34.4 (10–77)
Gender, %  
  Female 70.5
  Male 29.5
Race/Ethnicity, %  
  Caucasian 88.6
  Black 4.7
  Hispanic 4.7
  Other 2.0
Number of abdominal attacks per patient
  Mean (SD) 3.5 (4.0)
  Range 1-28
Total Attacks, n (%)  
  1 attack 57 (38)
  2 attacks 29 (19)
  3 attacks 24 (16)
  4 attacks 8 (5)
  5 attacks 6 (4)
  >5 attacks 25 (17)
  1. 1All patients treated with 30 mg subcutaneous ecallantide in EDEMA2, EDEMA3, EDEMA4 and DX-88/19 with any abdominal symptoms.